Saturday 17 October 2026 Export CSTL’s income statement to Excel — free account

Castle Biosciences, Inc.

Castle Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $344.2 million, up 3.66% from fiscal 2024. In the quarter to June 2026, revenue grew 20.1%, EPS fell 143.8%, free cash flow fell 43.3% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years.

31.96 1.84 −5.44%

Follow CSTL

Alert me

Market cap: $1.0B
P/E: 0.0×
Fwd P/E: −15.2×
Dividend yield: —
F-score: 3/9
Altman Z: 6.70
Beneish M: −3.49
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		1.93	3.28	2.16	2.03
P/FCF ratio Full definition →		26.04	39.74	160.88	0.00
P/Operating CF Full definition →		29.25	41.87	(33.16)	47.70
P/B ratio Full definition →		1.42	2.39	1.59	1.54
Price to Tangible BV Full definition →		1.81	3.04	2.02	1.93
EV/Sales Full definition →		1.13	2.44	1.42	1.31
EV/EBITDA Full definition →		142.99	0.00	0.00	0.00
EV/Operating CF Full definition →		6.26	13.03	10.00	10.99
EV/FCF Full definition →		15.21	29.55	105.78	(1,036.62)
Quick Ratio Full definition →		6.09	4.99	6.23	5.58
Current Ratio Full definition →		6.47	5.26	6.75	6.04
Net Debt/EBITDA Full definition →		71.19	381.44	16.83	(421.82)
Debt/Assets Full definition →		1.85%	1.79%	1.89%	1.84%
Debt/Equity Full definition →		0.02	0.02	0.02	0.02
Asset Turnover Full definition →		0.64	0.62	0.65	0.65
Operating CF/Net income Full definition →		(45.17)	(11.55)	1.52	(7.38)
Capex/Depreciation Full definition →		(5.09)	(2.34)	(3.58)	(2.35)
Interest Coverage Full definition →		(283.50)	(159.46)	(137.37)	(15.91)
Research and Development Expense of Revenue Full definition →		15.61%	15.53%	17.24%	14.04%
Selling, General and Administrative Expense of Revenue Full definition →		67.32%	65.20%	77.56%	63.86%
Intangible Assets out of Total Assets Full definition →		0.18	0.17	0.18	0.17
Share Based Compensation of Revenue Full definition →		14.57%	13.11%	11.68%	11.19%
Graham Net Nets Full definition →		0.40	0.22	0.33	0.34
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(1.84%)	(2.16%)	(1.75%)	(2.77%)
Free Cash Flow Yield Full definition →		3.84%	2.52%	0.62%	(0.06%)
Revenue per Share Full definition →		2.86	3.00	2.80	3.41
Operating CF per Share Full definition →		0.78	0.93	(0.74)	0.50
Capex per Share Full definition →		(0.51)	(0.25)	(0.42)	(0.28)
Free Cash Flow per Share Full definition →		0.27	0.68	(1.16)	0.22
Cash per Share Full definition →		9.89	10.33	8.76	8.78
Shareholders Equity per Share Full definition →		16.06	16.24	15.44	15.46
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		16.06	16.24	15.44	15.46
Free Cash Flow Full definition →		7.82	19.75	(34.58)	6.56
Working Capital Full definition →		302.26	292.42	280.14	284.59
Capital Expenditures Full definition →		(14.81)	(7.18)	(12.45)	(8.64)
Net Current Asset Value Full definition →		261.83	253.41	242.51	249.95
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.18	0.08	0.15	0.08
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		49.87	47.30	49.31	50.33
Average Payables Full definition →		9.51	12.81	11.77	11.42
Average Inventory Full definition →		7.61	9.19	8.66	9.47
Average Assets Full definition →		538.68	554.90	524.76	552.95
Average Common Equity Full definition →		454.05	463.35	450.86	462.70

Show all line items

Columns are period end dates

Stockrow Weekly